Pfizer Expands Color-Shifting Labels Beyond Viagra To Celebrex, Lipitor
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer is expanding its use of color-shifting labels beyond Viagra to five other products as part of its anti-counterfeiting efforts.
You may also be interested in...
FDA Alerts U.S. Residents To British Recall Of Counterfeit Lipitor
U.S. residents may have received the counterfeit statin if they purchased drugs online, from storefront operations that supply unapproved drugs, or through state-run drug importation programs, FDA warns.
FDA Alerts U.S. Residents To British Recall Of Counterfeit Lipitor
U.S. residents may have received the counterfeit statin if they purchased drugs online, from storefront operations that supply unapproved drugs, or through state-run drug importation programs, FDA warns.
FDA To Examine Safety Impact Of Color In Drug Labeling, Packaging
A March 7 public hearing will help the agency determine the benefits and potential drawbacks to patient safety. FDA seeks input on whether there are specific classes of drugs where use of color has demonstrated value or posed a hindrance to public safety.